Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haleon's experimental dentifrice for **tooth erosion** is a fixed-dose toothpaste formulation containing sodium fluoride that delivers 1,150 ppm fluoride and 5% potassium nitrate. It was evaluated in an examiner-blind, randomized crossover in situ study using acid-softened bovine enamel specimens worn intraorally. Fluoride is intended to increase enamel fluoride uptake, promote remineralization of softened enamel, and improve resistance to subsequent acid-mediated demineralization; potassium nitrate is a conventional dentifrice active used for dentinal-sensitivity relief. The formulation has no reported marketed brand name or sponsor development code.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on experimental dentifrice-HALEON-tooth erosion.